A phase II trial of methotrexate, vinblastine, doxorubicin, and clsplatin (MVAC) in metastatic cancer of the uterine cervix

C Papadimitriou; Meletios A Dimopoulos; Nikolaos Giannakoulis; K. Sarris; Georgios Vassilakopoulos; T. Akrivos; Zannis Voulgaris; George Vlahos; Peter Athanassiadis

doi:10.1016/s0959-8049(97)85703-6

Related publications

Article1997

A Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix

Christos Papadimitriou, Meletios A Dimopoulos, Nikolaos Giannakoulis, K. Sarris, Georgios Vassilakopoulos, T. Akrivos, Zannis Voulgaris, Georgios Vlahos, E Diakomanolis, Stylianos Michalas

Article1999

Phase II Trial of Paclitaxel and Cisplatin in Metastatic and Recurrent Carcinoma of the Uterine Cervix

Christos Papadimitriou, K. Sarris, Lia A. Moulopoulos, George Fountzilas, Athanassios Anagnostopoulos, Zannis Voulgaris, Dimitra Gika, Nikolaos Giannakoulis, Emmanuel Diakomanolis, Meletios A Dimopoulos

Article1997

Cisplatin, Ifosfamide, Methotrexate and Vinblastine Combination Chemotherapy for Metastatic Urothelial Cancer

Zacharias Kyriakakis, Meletios A Dimopoulos, A. Kostakopoulos, Aristidis Karayiannis, F. Sofras, Anastasios Zervas, Aristidis Giannopoulos, C Dimopoulos

Article1997

Cisplatin, Ifosfamide, Methotrexate and Vinblastine Combination Chemotherapy for Metastatic Urothelial Cancer

Zacharias Kyriakakis, Meletios A Dimopoulos, A. Kostakopoulos, Aristidis Karayiannis, F. Sofras, Anastasios Zervas, Aristidis Giannopoulos, C Dimopoulos

Article2002

Combination of Ifosfamide, Paclitaxel, and Cisplatin for the Treatment of Metastatic and Recurrent Carcinoma of the Uterine Cervix: A Phase II Study of the Hellenic Cooperative Oncology Group

Meletios A Dimopoulos, Christos Papadimitriou, K. Sarris, Gerasimos Aravantinos, Charalambos Kalofonos, Dimitra Gika, Georgios M. Gourgoulis, Eleni Efstathiou, Dimosthenis Skarlos, Dimitrios Bafaloukos

A phase II trial of methotrexate, vinblastine, doxorubicin, and clsplatin (MVAC) in metastatic cancer of the uterine cervix

Discussion(0)

Related publications

A Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix

Phase II Trial of Paclitaxel and Cisplatin in Metastatic and Recurrent Carcinoma of the Uterine Cervix

Cisplatin, Ifosfamide, Methotrexate and Vinblastine Combination Chemotherapy for Metastatic Urothelial Cancer

Cisplatin, Ifosfamide, Methotrexate and Vinblastine Combination Chemotherapy for Metastatic Urothelial Cancer

Combination of Ifosfamide, Paclitaxel, and Cisplatin for the Treatment of Metastatic and Recurrent Carcinoma of the Uterine Cervix: A Phase II Study of the Hellenic Cooperative Oncology Group